- Associated Press - Wednesday, January 6, 2016

ALBUQUERQUE, N.M. (AP) - Researchers in New Mexico plan to reach out to drug users for inclusion in a nationwide study of hepatitis C treatments.

The Albuquerque Journal reports (https://bit.ly/1ZNJEby ) that the University of New Mexico will receive $2.3 million to compare two models for treating the virus, which is often transmitted when people injecting drugs share needles.

The project is funded by the Washington D.C.-based nonprofit Patient-Centered Outcomes Research Institute. The research institute says injection drug users rarely get the most effective hepatitis C treatments.

UNM is one of eight places that will participate in the $14 million five-year study, treating an estimated 1,000 people nationally.

Hepatitis C infects up to 35,000 people in New Mexico and is the leading cause of liver transplants.



___

Information from: Albuquerque Journal, https://www.abqjournal.com

Sign up for Daily Newsletters

Manage Newsletters

Copyright © 2020 The Washington Times, LLC.

Please read our comment policy before commenting.

 

Click to Read More and View Comments

Click to Hide